Rachel Sha

President at Vaxess Technologies.

Cambridge, MA
Form D signer
Vaxess Technologies

Raised on Vaxess Technologies filings

$73.6M

of $103.5M offered across 3 Form D filings

Form D filings: 3
Teammates: 2
Last filing: Mar 19, 2026

Company

Vaxess Technologies

Biotech · Cambridge, MA

Dissolvable microarray patches for vaccines

Dissolvable microarray patches for vaccines

Investors: 3
Still open: $29.9M

Investors: 3
Sector: Biotech
HQ: Cambridge, MA

Vaxess Technologies filings

Vaxess Technologies Form D filings
Filed	Security	Sold of offered	Filing
Mar 19, 2026	Equity	$57.3M/ $83.5M	Form D
Sep 10, 2025	Debt	$7.9M/ $10M	Form D
Feb 26, 2025	Debt	$8.4M/ $10M	Form D

EquityFiled Mar 19, 2026Form D
$57.3M/ $83.5M
DebtFiled Sep 10, 2025Form D
$7.9M/ $10M
DebtFiled Feb 26, 2025Form D
$8.4M/ $10M

Works with

Also named on Vaxess Technologies filings

Linda TusseyExecutive Officer Weiner TilsnerExecutive Officer